These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Physician-guided treatment compared with a heparin protocol for deep vein thrombosis. Elliott CG; Hiltunen SJ; Suchyta M; Hull RD; Raskob GE; Pineo GF; Jensen RL; Yeates S; Kitterman N Arch Intern Med; 1994 May; 154(9):999-1004. PubMed ID: 8179457 [TBL] [Abstract][Full Text] [Related]
4. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224 [TBL] [Abstract][Full Text] [Related]
6. Relationship of activated partial thromboplastin time to coronary events and bleeding in patients with acute coronary syndromes who receive heparin. Anand SS; Yusuf S; Pogue J; Ginsberg JS; Hirsh J; Circulation; 2003 Jun; 107(23):2884-8. PubMed ID: 12796128 [TBL] [Abstract][Full Text] [Related]
7. Heparin dosage adjustment in patients with deep-vein thrombosis using heparin concentrations rather than activated partial thromboplastin time. Groce JB; Gal P; Douglas JB; Steuterman MC Clin Pharm; 1987 Mar; 6(3):216-22. PubMed ID: 3665377 [TBL] [Abstract][Full Text] [Related]
8. [The impact of heparin bolus from dysfunctional lumen of dual lumen central venous catheter on activated partial thromboplastin time during hemodialysis: is additional heparinization necessary?]. Sefer S; Kes P; Raić B; Heinrich B; Degoricija V; Szavits-Nossan J Acta Med Croatica; 2006 Jun; 60(3):281-5. PubMed ID: 16933844 [TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
10. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related]
11. Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature. Myzienski AE; Lutz MF; Smythe MA Pharmacotherapy; 2010 Mar; 30(3):324. PubMed ID: 20180615 [TBL] [Abstract][Full Text] [Related]
12. Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications. Floroff CK; Palm NM; Steinberg DH; Powers ER; Wiggins BS Pharmacotherapy; 2017 Apr; 37(4):393-400. PubMed ID: 28107569 [TBL] [Abstract][Full Text] [Related]
13. Complications of heparin therapy. Gervin AS Surg Gynecol Obstet; 1975 May; 140(5):789-96. PubMed ID: 1170648 [TBL] [Abstract][Full Text] [Related]
14. Inability of the activated partial thromboplastin time to predict heparin levels. Time to reassess guidelines for heparin assays. Baker BA; Adelman MD; Smith PA; Osborn JC Arch Intern Med; 1997 Nov; 157(21):2475-9. PubMed ID: 9385299 [TBL] [Abstract][Full Text] [Related]
15. [Heparin in deep venous thrombosis of the leg--effectiveness and safety]. Gatterer E; Stöllberger C; Slany J; Stöberl C; Jaksch J Wien Klin Wochenschr; 1988 Sep; 100(18):601-5. PubMed ID: 3188535 [TBL] [Abstract][Full Text] [Related]
16. Heparin therapy in pediatric patients: a prospective cohort study. Andrew M; Marzinotto V; Massicotte P; Blanchette V; Ginsberg J; Brill-Edwards P; Burrows P; Benson L; Williams W; David M Pediatr Res; 1994 Jan; 35(1):78-83. PubMed ID: 8134203 [TBL] [Abstract][Full Text] [Related]
17. An evaluation of APTT monitoring of low-dose heparin dosage in hip surgery. Poller L; Taberner DA; Sandilands DG; Galasko CS Thromb Haemost; 1982 Feb; 47(1):50-3. PubMed ID: 7071805 [TBL] [Abstract][Full Text] [Related]
18. Appropriate use of heparin. Empiric vs nomogram-based dosing. Gunnarsson PS; Sawyer WT; Montague D; Williams ML; Dupuis RE; Caiola SM Arch Intern Med; 1995 Mar; 155(5):526-32. PubMed ID: 7864708 [TBL] [Abstract][Full Text] [Related]